Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹75.07down ₹1.53 (2.00%)BSE ₹75.50
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
52-week range of traded prices to 2 Nov 2026
₹44.10Low, 30 Mar 2026₹96.00High, 6 Nov 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 29 of 30.
May 2010
6 May · Board meeting
To consider and take on record: 1) Unaudited Financial Results for the quarter ended March 31, 2010. 2) Unaudited financial results of the Company together with that of Lyka BDR International Ltd a Subsidiary for the quarter ended March 31, 2010.
Apr 2010
Mar 2010
4 Mar · Limited Review for the quarter ended Dec 31, 2009
2 Mar · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
27 Feb · Lyka Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from March 25, 2010 to March 30, 2010 (both days inclusive) for the ....
Fixes Book Closure for AGM24 Feb · Results
24 Feb · Meeting
In the Board Meeting held on February 23, 2010, the Board of Directors have adopted the following : The Annual General Meeting is convened on March 30, 2010. The Share Transfer Books and Register of Members will remain closed for a period of 6 days from March 25, 2010 to March 30, 2010. (Both days inclusive) for the purpose of AGM.15 Feb · Board meeting
For : (1) Adoption of Audited Annual Accounts for the period of 18 months ended September 30, 2009. (2) Adoption of Audited Consolidated Annual Accounts for the period ended September 30, 2009 and (3) Taking on record the Consolidated Unaudited Financial Results for the Quarter ended December 31, 2009.
Jan 2010
30 Jan · Results
18 Jan · Board meeting
Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Dec 2009
7 Dec · Meeting
We have sought extension of three months for holding Annual General Meeting for the Financial Year ended September 30, 2009 up to March 31, 2010 vide approval dated April 28, 2009 received from the Office of Registrar of Companies, Gujarat
Nov 2009
24 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the Eighteen Months ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Nov · Audit Qualifications/Management Comments
Vide notes to Accounts in the Unaudited Financial Results (Provisional) for the quarter ended September 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on October 30, 2009) regarding Audit qualifications in respect of Audited Accounts for 2007-08 and management comments thereon are detailed below : a) The deferment of R&D expenditure of Rs. 2,75,14,204/- which is not in compliance with Accounting Standard (AS-26). The company has explained at note No.13 to the accounts; b) Regarding non-provision of slow/non moving inventories of Rs.1,21,68,172/- as explained at note No.14 to the accounts.
Oct 2009
22 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the sixth quarter ended September 30, 2009.9 Oct · Management
The term of office of Shri. R. A. S. Iyer as Executive Director ended on 31.07.2009 and accordingly he ceased to be Executive Director of the Company. However, he continues to be Non-Executive Director on the Board.
Sep 2009
8 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009 and Fifteen months ended June 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
7 Aug · Management
At the Board Meeting held on July 31, 2009, Shri. V. S. Taksali - Executive Director whose term of office ended on July 31, 2009 has been re-appointed as Executive Director for a period of 2 years w.e.f. August 01, 2009 on revised terms and conditions. Further, the Company has informed the Exchange that the term of office of Shri. R. A. S. Iyer as Executive Director has ended on July 31,2009. Hence he ceases to be the Executive Director of the Company from July 31, 2009.
Jul 2009
20 Jul · Board meeting
Meeting on 31 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
1 Jun · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended March 31, 2009. The Limited Review Report and reasons for variation have been approved by the Board of Directors at their meeting held on May 29, 2009.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporate > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
27 May · Updates
Our Bulk Drug Plant at Ankleshwar which was closed for the purpose of upgradation has been restarted13 May · Subsidiary
Lyka BDR International Ltd has become a subsidiary of the Company.5 May · Management
Mr. D.G. Shah has resigned as Director of the Company effective from April 21, 20095 May · Management
Shri. N. I. Gandhi has been re-appointed as Managing Director of the Company w.e.f. 1st April, 2009, subject to approval of the Central Government
Apr 2009
30 Apr · Extension of Financial Year
Company has extended the Financial Year ending from March 31, 2009 to September 30, 2009 and thereby the Company will prepare Annual Accounts for a period of 18 months commencing from April 01, 2008 to September 30, 2009. The Company has received the approval from the Registrar of Companies, Gujarat.20 Apr · Board meeting
Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
Mar 2009
31 Mar · Meeting
Notice of the Extraordinary General Meeting of the members of the Company to be held on April 23, 2009 for obtaining approval of Shareholders to the re-appointment of Shri. N.I. Gandhi as Managing Director of the Company w.e.f. April 1, 2009 for further period of 5 years. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
27 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Feb · Disclosure
Details of total number of shares held by Promoter Group and total number of shares pledged by them. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
30 Jan · Audit Qualifications/Management Comments
Vide notes to Accounts in the Unaudited Financial Results (Provisional) for the quarter ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 30, 2009) regarding Audit qualifications in respect of Audited Accounts for 2007-08 and management comments thereon are detailed below : a) The deferment of R&D expenditure of Rs. 2,75,14,204/- which is not in compliance with Accounting Standard (AS-26). The company has explained at note No.13 to the accounts; b) Regarding non-provision of slow/non moving inventories of Rs.1,21,68,172/- as explained at note No.14 to the accounts.30 Jan · Updates
One of our unit at Ankleshwar, namely Bulk Drug Plant will remain closed upto the end of Febuary, 2009 for the purpose of maintenance and upgradation.19 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
28 Nov · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the six months ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Nov · Meeting
Minutes of the Annual General Meeting of the members of the Company to be held on October 16, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
25 Oct · Company's Comments on Audit Qualifications
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on October 24, 2008) regarding Audit qualifications in respect of Audited Accounts for 2007-08 and management comments thereon are detailed below : a) The deferment of R&D expenditure of Rs. 2,75,14,204/- which is not in compliance with Accounting Standard (AS-26). The company has explained at note No.13 to the accounts; b) Regarding non-provision of slow/non moving inventories of Rs.1,21,68,172/- as explained at note No.14 to the accounts.15 Oct · Board meeting
Meeting on 24 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Sep 2008
11 Sep · Demise of Director
Our Director - Shri, Vijay Chimanlal Sanghavi expired on 10th September, 20088 Sep · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Sep · Meeting
Board of Directors at its meeting held on August 29, 2008 has decided to hold the Annual General Meeting of the Company on October 16, 2008. The company obtained permission from the Registrar of Companies, Gujarat for holding AGM upto October 31, 2008. The Register of Members and Share transfer Books will remain closed from October 10, 2008 to October 16, 2008 (both days inclusive). Further the company has submitted a copy of the Financial Highlights for the period ended March 31, 2008. Copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
22 Aug · Board meeting
To consider Adoption of Account for the year ended March 31, 2008.18 Aug · Board meeting postponed
Due to unavoidable circumstance the Board Meeting scheduled to be held on August 20, 2008 for considering the Annual Accounts has been postponed and the new date will be informed to you shortly.